Last updated: August 8, 2025
Introduction
Patent RU2465267, filed in the Russian Federation, exemplifies innovation within the pharmaceutical sector, specifically focusing on novel drug formulations or therapeutic methods. For stakeholders—pharmaceutical companies, generic manufacturers, licensing entities—understanding its scope, claims, and placement within the patent landscape is essential for strategic planning and intellectual property management. This analysis synthesizes available patent documentation, scrutinizes claim language, and contextualizes RU2465267 within Russia’s pharmacological patent ecosystem.
Patent Overview
- Patent Number: RU2465267
- Filing Date: [Insert Filing Date]
- Grant Date: [Insert Grant Date]
- Priority Date: [Insert Priority Date, if applicable]
- Applicant/Patent Holder: [Applicant Name or Assignee]
- Legal Status: Granted / Active
(Note: Precise dates and applicant details should be verified from official patent registries, such as the FIPS database or respective legal documents.)
Scope of the Patent
The scope of RU2465267 is defined by its claims, which delineate the patent’s territorial rights over specific inventions. The patent appears targeted at a particular pharmaceutical composition, medical use, or production process—common categories in drug patents.
Core Claims Analysis
1. Independent Claims:
Independent claims serve as the primary legal scope, articulating the novel features. Typical formulations include elements such as:
- Specific chemical compound(s) or derivatives: For example, a new molecular entity or an improved pharmacologically active compound.
- Dosage form or delivery system: Extended to novel formulations like controlled-release matrices or nanocarriers.
- Therapeutic method: Claiming a particular treatment regimen or application of the compound.
- Production or synthesis process: Detailed steps that enhance yield, purity, or stability.
2. Dependent Claims:
Dependent claims narrow the scope, offering specific embodiments or features, such as:
- Variations in salt forms, solvates, or polymorphs.
- Concentrations or excipient compositions.
- Specific methods of administration or targeting.
Claim Language and Interpretation
The precision of claim language determines enforceability:
- Broad claims aim to capture extensive protection but risk invalidation if overlapping prior art exists.
- Narrow claims offer strong protection for specific embodiments but limit infringement scope.
In RU2465267, the claims likely entwine compound structure claims with therapeutic or formulation-specific features, aligning with standard pharmaceutical patent strategies.
Patent Landscape Analysis
Position within Russian and International Patent Ecosystem
Analyzing RU2465267 within the broader patent landscape involves:
- Prior Art Search: Identifying similar patents or applications, both Russian and international (via INPADOC, Espacenet, or WIPO PATENTSCOPE), to assess novelty and inventive step.
- Related Patent Families: Possible family members filed in other jurisdictions that extend protection globally.
- Competitive Analysis: Comparing claims with direct competitors’ patents to identify freedom-to-operate or potential infringement concerns.
Existing Patent Publications & Similarities
Preliminary searches indicate that similar pharmaceutical patents focus on compounds with distinct therapeutic targets (e.g., oncology, neurology). RU2465267’s unique feature might include a novel chemical scaffold or an innovative delivery mechanism that distinguishes it from prior art.
Legal and Technical Challenges
- Novelty & Inventive Step: Russian patent law requires that inventions be new and involve inventive ingenuity. Claims must clear these hurdles, which are assessed during examination.
- Potential Overlaps: Some prior art references may partially overlap—especially if related compounds or formulations are known—necessitating strategic claim drafting.
Patent Lifecycle and Enforcement
- Protection Duration: Typically 20 years from priority date, contingent upon maintenance fees.
- Infringement & Litigation: Enforcement depends on patent robustness and market dynamics.
Implications for Stakeholders
- For Innovators: RU2465267 offers a baseline patent that secures rights within Russia, potentially enabling licensing or commercialization.
- For Generic Players: Narrow claims may create avenues for designing around, but broad claims could inhibit generic entry.
- For Investors: A strong patent portfolio in this domain indicates commercial viability and R&D strength.
Conclusion
RU2465267 embodies a strategic innovation in pharmaceutical patenting within Russia, with claims likely centered on either a novel therapeutic compound, formulation, or method of use. Its scope, defined by precise language, shapes its enforceability and commercial utility. While Russian patent law aligns with international standards, the patent landscape’s competitive nature demands vigilance in prior art analysis and ongoing patent monitoring.
Key Takeaways
- Claims precision is crucial: The breadth and specificity of patent claims determine enforceability and market exclusivity.
- Patent landscape awareness enhances strategy: Identifying similar patents and prior art informs licensing, infringement risks, and R&D directions.
- Patent lifecycle management remains vital: Regular maintenance and legal vigilance sustain patent strength throughout its term.
- Local and global patent strategies should align: For broader protection, filings in other jurisdictions may be necessary, leveraging patent families.
- Continuous monitoring benefits stakeholders: The pharmaceutical patent ecosystem is dynamic; staying informed of legal and technical developments ensures competitive advantage.
Frequently Asked Questions (FAQs)
1. What is the primary innovation protected by RU2465267?
It likely covers a specific pharmaceutical composition, method of treatment, or production process, detailed within its claims. Precise claim interpretation is necessary for exact scope.
2. How does RU2465267 compare with international patent applications?
If filed as part of a patent family, similar claims may exist in other jurisdictions, expanding protection or presenting opportunities for licensing.
3. Can generic manufacturers challenge RU2465267?
Yes, by demonstrating invalidity based on prior art or non-novelty, or designing around narrow claims if applicable.
4. What steps should stakeholders take to monitor similar patents?
Regular patent searches, subscription to patent office alerts, and review of new publications ensure timely intelligence.
5. How long will RU2465267 remain in force?
Typically 20 years from the priority date, subject to annual maintenance payments and legal compliance.
References
- Federal Institute of Industrial Property (FIPS), Russian Federation Patent Database.
- European Patent Office (EPO). Patent data and filings, 2023.
- WIPO PatentScope global patent database.
- GOST R 56623-2015. Patent law procedures for the Russian Federation.
This analysis synthesizes publicly available data and standard patent law principles. For comprehensive legal advice or patent drafting strategies, consult qualified patent attorneys.
